Cell Therapeutics drug draws US FDA staff concerns

	Biotech firm Cell Therapeutics is getting a snow day -- and a reprieve from what will likely be harsh criticism of its drug. The company was set to face a... More
Forbes (blog) ( 2/8/2010 6:36:38 PM -08:00 )

Cell Therapeutics drug draws US FDA staff concerns

WASHINGTON, Feb 8 (Reuters) - US drug reviewers questioned effectiveness data from Cell Therapeutics Inc (CTIC.O) (CTIC.... More

Reuters ( 2/8/2010 4:48:26 PM -08:00 )

Tough Questions Await Cell Therapeutics' Cancer Drug

Cell Therapeutics' experimental lymphoma drug pixantrone faces rough sledding from an FDA advisory committee after an agency staff review... More

Wall Street Journal (blog) ( 2/8/2010 9:43:47 AM -08:00 )

Drug stocks turn higher; Cell Therapeutics, Novavax slide

The NYSE Arca Pharmaceutical Index (INDEX:DRG) and the NYSE Arca Biotechnology Index (INDEX:BTK) were both up 0.4% at... More

MarketWatch ( 2/8/2010 11:10:18 AM -08:00 )

Abridged Study to Haunt CTI? FDA Questions Pixantrone Data

Shares of Cell Therapeutics Inc. tumbled 39.6 percent after FDA briefing documents, emerging ahead of Wednesday's advisory panel,... More

BioWorld Online ( 2/8/2010 5:47:59 PM -08:00 )

FDA Announces Inadequate Clinical Data on Proposed Cancer Drug Pixantrone

The Food and Drug Administration on Monday announced that there was insufficient clinical evidence involving a proposed Cell Therapeutics, Inc. drug that... More

TopNews New Zealand ( 2/8/2010 2:48:13 PM -08:00 )

Cell Therapeutics' Last Hope for Survival, Dashed

Cell Therapeutics (CTIC) took a dive into the penny-stock territory on Monday after documents were released by the FDA... More

Minyanville.com ( 2/8/2010 11:20:38 AM -08:00 )

Cell Therapeutics Sours as it Seeks FDA Approval

Cell Therapeutics (CTIC) has long been one of the stocks I've told people to avoid. The latest attempt from this... More

Minyanville.com ( 2/8/2010 11:09:01 AM -08:00 )

FDA Tough on Cell Therapeutics' Drug
	WASHINGTON (TheStreet) -- Last week, I laid out in detail seven reasons why the US Food and Drug Administration... More
TheStreet.com ( 2/8/2010 10:11:15 AM -08:00 )

Shares of CTI tumble 25%

Cell Therapeutics Inc. lost more than 25 percent of it value this morning after the US Food and Drug Administration questioned whether the Seattle biotech... More

TechFlash (blog) ( 2/8/2010 8:59:57 AM -08:00 )

Cell Therapeutics Shares Fall as FDA Says Lymphoma Drug Has “Substantial” Side

Seattle-based Cell Therapeutics' experimental drug for non-Hodgkin's lymphoma was tested in “substantially fewer” patients than planned in a pivotal... More

Xconomy ( 2/8/2010 6:53:49 AM -08:00 )

Cell Therapeutics - Facing The Big Test

(RTTNews) - The Food and Drug Administration's Oncologic Drugs Advisory Committee is scheduled to review Cell Therapeutics Inc.'s (CTIC: News ) New Drug... More

RTT News ( 2/8/2010 12:35:09 AM -08:00 )

Cell Therapeutics stock plunges on negative FDA review

Shares of Seattle-based Cell Therapeutics plummeted Monday after the Food and Drug Administration raised serious questions about the safety and... More

Seattle Times ( 2/8/2010 12:11:34 PM -08:00 )

FDA: Limited Clinical Data On Proposed Cancer Drug Pixantrone

WASHINGTON (Dow Jones)--The Food and Drug Administration said Monday there was limited clinical evidence... More

Wall Street Journal ( 2/8/2010 6:42:28 AM -08:00 )

FDA staff questions Cell Therapeutics drug data

WASHINGTON (Reuters) - US drug reviewers questioned effectiveness data from Cell Therapeutics Inc for an experimental lymphoma drug and said the medicine... More

National Post ( 2/8/2010 6:33:40 AM -08:00 )

Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2009

SEATTLE, Feb 08, 2010 /PRNewswire via COMTEX/ -- On Thursday, February 11, 2010, at 8:30 am Eastern/2:30 pm Central European/5:30 am Pacific,... More

MarketWatch ( 2/7/2010 10:36:56 PM -08:00 )

Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2009

SEATTLE, Feb. 8 /PRNewswire-FirstCall/ -- On Thursday, February 11, 2010, at 8:30 am Eastern/2:30 pm Central European/5:30 am Pacific, members of Cell... More

CNNMoney.com (press release) ( 2/7/2010 10:36:27 PM -08:00 )

Cell Therapeutics Lymphoma Drug Faces FDA Questioning

Lymphoma drug pixantrone, made by Cell Therapeutics (CTIC), is facing tough questions from the Food and Drug Administration. The experimental drug went... More

FOXBusiness ( 2/8/2010 2:27:00 PM -08:00 )

FDA questions Cell Therapeutics' pixantrone

Ahead of Wednesday's advisory committee meeting, FDA staffers have raised questions about Cell Therapeutics' lymphoma drug pixantrone.... More

FierceBiotech ( 2/8/2010 8:18:32 AM -08:00 )

FDA Raises Concerns About Cell Therapeutics' Cancer Drug

WASHINGTON (TheStreet) -- Drug reviewers working for the Food and Drug Administration raised concerns about the... More

TheStreet.com ( 2/8/2010 6:01:31 AM -08:00 )